Cite
Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer.
MLA
Jin-Hyeok Hwang, et al. “Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer.” PLoS ONE, vol. 5, no. 5, May 2010, pp. 1–12. EBSCOhost, https://doi.org/10.1371/journal.pone.0010630.
APA
Jin-Hyeok Hwang, Voortman, J., Giovannetti, E., Steinberg, S. M., Leon, L. G., Yong-Tae Kim, Funel, N., Joo Kyung Park, Kim, M. A., Gyeong Hoon Kang, Sun-Whe Kim, del Chiaro, M., Peters, G. J., & Giaccone, G. (2010). Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer. PLoS ONE, 5(5), 1–12. https://doi.org/10.1371/journal.pone.0010630
Chicago
Jin-Hyeok Hwang, Johannes Voortman, Elisa Giovannetti, Seth M. Steinberg, Leticia G. Leon, Yong-Tae Kim, Niccola Funel, et al. 2010. “Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer.” PLoS ONE 5 (5): 1–12. doi:10.1371/journal.pone.0010630.